Vaniqa
Product Images NDC 54868-5124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vaniqa (NDC 54868-5124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Vaniqa Carton Label (5124)

Vaniqa Carton Label (5124)
FDA Label Image

Study 1 (Study 1)

Study 1 (Study 1)
FDA Label Image

Study 2 (Study 2)

Study 2 (Study 2)
The text provides information on a study with two treatment groups, but the content of the treatments or the purpose of the study is not available. The text also lists the duration of the treatment as 20 weeks. Therefore, a possible description could be "This text describes a study with two treatment groups and a duration of 20 weeks, but no information is available about the content or purpose of the treatments."*
FDA Label Image

Eflornithine Hydrochloried Chemical Structure (Eflornithine Hydrochloride Chemical Structure)

Eflornithine Hydrochloried Chemical Structure (Eflornithine Hydrochloride Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.